Toxoplasma gondii IgG Seroprevalence in HIV/AIDS Patients
PDF
Cite
Share
Request
Original Investigation
P: 65-67
June 2011

Toxoplasma gondii IgG Seroprevalence in HIV/AIDS Patients

Turkiye Parazitol Derg 2011;35(2):65-67
1. Sağlık Bakanlığı Haseki Eğitim ve Araştırma Hastanesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Bölümü, İstanbul, Türkiye
No information available.
No information available
Received Date: 21.12.2010
Accepted Date: 07.03.2011
PDF
Cite
Share
Request

ABSTRACT

Objective:

Our aim was to determine the Toxoplasma gondii IgG seroprevalence in HIV/AIDS patients who applied to our outpatient clinic.

Methods:

Between January 2006 and June 2010, 164 HIV/AIDS patients were tested for Toxoplasma gondii IgG antibodies by using the ELISA method.

Results:

Of the total of 164 HIV/AIDS patients, 135 were male, 29 were female with a mean age of 36 years (range: 20-72 years). 85 (52%) of cases, T. gondii IgG was evaluated positive. In addition, positive T. gondii IgG was seen in 23 of 36 patients (64%) whose count of CD4+T cell was below 100.

Conclusion:

Life threatening clinical conditions, mostly toxoplasma encephalitis, develop in cases who are T. gondii IgG seropositive with a count of CD4+ T cell lower than 100. The presence of T. gondii IgG should be investigated in all HIV infected patients due to the high risk of reactivation.

Keywords: HIV/AIDS, Toxoplasma gondii IgG, seroprevalence

References

2024 ©️ Galenos Publishing House